Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DX25F5ZYF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $22,608
Award facts
- Contract value 100% obligated
- $22,608.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $22.6K by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for the supply of Exparel 133 mg/10 mL vials. This firm fixed-price delivery order, with an ultimate completion date of June 24, 2025, represents a direct fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the company to compete on its merits as a woman-owned small business in the federal pharmaceutical procurement market.
This delivery order exemplifies DMS Pharmaceutical Group's core operational focus within the federal pharmaceutical supply chain, leveraging its $500M indefinite delivery vehicle with the DLA under the SPE2DB program to provide specialized medical products to Department of Defense healthcare facilities. Exparel, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management, supports critical clinical applications across military medical treatment facilities. The company's positioning as a primary pharmaceutical distributor enables rapid fulfillment of targeted medical supply requirements while maintaining the pricing and service standards established under its overarching contract framework.
Quick answers
Who was awarded contract SPE2DX25F5ZYF?
SPE2DX25F5ZYF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 2, 2025.
How much is contract SPE2DX25F5ZYF worth?
The government has obligated $22,608 on SPE2DX25F5ZYF.
Is contract SPE2DX25F5ZYF an order under another contract?
Yes. SPE2DX25F5ZYF is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F5ZYF competed?
The extent of competition for SPE2DX25F5ZYF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award